Macular edema after siponimod treatment for multiple sclerosis: a case report and literature review

BACKGROUND: As a modulator of the sphingosine 1-phosphate receptor, siponimod is administered as a therapeutic intervention for multiple sclerosis. A previous phase 3 study first reported siponimod-associated macular edema. Since that report, there were only few relevant reports in clinical settings...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qingsheng, Jing, Li-Jun, Li, Yanfei, Jia, Yanjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391854/
https://www.ncbi.nlm.nih.gov/pubmed/37525104
http://dx.doi.org/10.1186/s12883-023-03333-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391854/
https://www.ncbi.nlm.nih.gov/pubmed/37525104
http://dx.doi.org/10.1186/s12883-023-03333-0

Ejemplares similares